Media
Here in the media centre you will find a range of resources including our latest and archived press releases, statements from our CEO, speeches and presentations, information on our social media policy, and our photo and video library.
Find the latest and archived speeches and presentations from GSK’s senior executives.
Press releases
GlaxoSmithKline announces start of phase III study of Benlysta® (belimumab ) in patients with vasculitis
GlaxoSmithKline plc (GSK) today announced the start of a Phase III study to evaluate Benlysta® (belimumab) in patients with ANCA (Anti-neutrophil Cytoplasmic Antibodies) positive vasculitis – a condition that involves inflammation of the blood vessels.
GSK announces first four-strain seasonal influenza vaccine granted marketing authorisation in Germany and the UK
GlaxoSmithKline plc has announced the marketing authorisation of its quadrivalent (four-strain) influenza vaccine in Germany and the UK.
Regulatory update: GlaxoSmithKline receives complete response from FDA for candidate pandemic H5N1 adjuvanted influenza vaccine
GlaxoSmithKline [NYSE:GSK] announced today that it has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) in response to the Biologics License Application (BLA) for its Pandemic Influenza A Virus Monovalent Adjuvanted candidate vaccine, referred to as Q-Pan H5N1.
